Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case report

C Xi, Z Wencheng, Q Dong, G Yong, Y Cihui… - Cancer biology & …, 2019 - Taylor & Francis
ABSTRACT The PD-1/PD-L1 axis is characterized as an important checkpoint of immune
activation, particularly through negatively regulating T cell function. Although accumulated …

[引用][C] Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case report

C Xi, Z Wencheng, Q Dong, G Yong, Y Cihui… - Cancer Biology & …, 2018 - cir.nii.ac.jp
Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a
patient with metastatic mediastinal leiomyosarcoma: a case report | CiNii Research CiNii 国立 …

Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case report

C Xi, Z Wencheng, Q Dong, G Yong… - Cancer biology & …, 2019 - pubmed.ncbi.nlm.nih.gov
The PD-1/PD-L1 axis is characterized as an important checkpoint of immune activation,
particularly through negatively regulating T cell function. Although accumulated evidence …

Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case report.

C Xi, Z Wencheng, Q Dong, G Yong, Y Cihui… - Cancer Biology & …, 2018 - europepmc.org
ABSTRACT The PD-1/PD-L1 axis is characterized as an important checkpoint of immune
activation, particularly through negatively regulating T cell function. Although accumulated …

[HTML][HTML] Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case …

C Xi, Z Wencheng, Q Dong, G Yong… - Cancer Biology & …, 2019 - ncbi.nlm.nih.gov
ABSTRACT The PD-1/PD-L1 axis is characterized as an important checkpoint of immune
activation, particularly through negatively regulating T cell function. Although accumulated …

Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case report.

C Xi, Z Wencheng, Q Dong, G Yong, Y Cihui… - Cancer Biology & …, 2018 - europepmc.org
ABSTRACT The PD-1/PD-L1 axis is characterized as an important checkpoint of immune
activation, particularly through negatively regulating T cell function. Although accumulated …